Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The influence of age and cardiorespiratory fitness on bioactive lipids in muscle

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Relationship between Cognitive Impairment and Upper Extremity Function in Older Primary Care Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effects of Exercise Training on Regulation of Skeletal Muscle Glucose Metabolism in Elderly Men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Longitudinal Changes in Leukocyte Telomere Length and Mortality in Humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Mild Cognitive Impairment Status and Mobility Performance: An Analysis From the Boston RISE Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: To understand and measure the association between chronic inflammation, aging, and age-related diseases, broadly applicable standard biomarkers of systemic chronic inflammation are needed. We tested whether elevated blood levels of the emerging chronic inflammation marker soluble urokinase plasminogen activator receptor (suPAR) were associated with accelerated aging, lower functional capacity, and cognitive decline.

METHODS: We used data from the Dunedin Study, a population-representative 1972-1973 New Zealand birth cohort (n = 1037) that has observed participants to age 45 years. Plasma suPAR levels were analyzed at ages 38 and 45 years. We performed regression analyses adjusted for sex, smoking, C-reactive protein, and current health conditions.

RESULTS: Of 997 still-living participants, 875 (88%) had plasma suPAR measured at age 45. Elevated suPAR was associated with accelerated pace of biological aging across multiple organ systems, older facial appearance, and with structural signs of older brain age. Moreover, participants with higher suPAR levels had greater decline in physical function and cognitive function from childhood to adulthood compared to those with lower suPAR levels. Finally, improvements in health habits between ages 38 and 45 (smoking cessation or increased physical activity) were associated with less steep increases in suPAR levels over those years.

CONCLUSIONS: Our findings provide initial support for the utility of suPAR in studying the role of chronic inflammation in accelerated aging and functional decline.

OriginalsprogEngelsk
TidsskriftJournals of Gerontology. Series A: Biological Sciences & Medical Sciences
ISSN1079-5006
DOI
StatusUdgivet - 16 jul. 2020

Bibliografisk note

© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America.

ID: 60614308